-
Risdiplam Questions For Roche Genentech And Our Insurance Companies
In this episode of the Morale Monologue, I’m giving you my opinions to questions that were asked regarding Roche/Genentech’s new potential treatment known as risdiplam. These questions dealt specifically with Roche/Genentech and our insurance companies, and I believe that these are questions that will need to be answered before the FDA gives their final decision as to the approval or denial of risdiplam.
===============================
Are you interested in learning more about spinal muscular atrophy? If so, please login to http://www.smanewstoday.com
===============================
Sorry, there were no replies found.
Log in to reply.